证券代码：301111 证券简称：粤万年青 公告编号：2025-032 广东万年青制药股份有限公司 关于使用部分闲置募集资金（含超募资金）和自有资金进行 现金管理到期赎回并继续进行现金管理的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 广东万年青制药股份有限公司（以下简称"公司"）于 2024 年 12 月 18 日召 开第三届董事会第四次会议及第三届监事会第四次会议，并于 2025 年 1 月 3 日 召开 2025 年第一次临时股东大会，审议通过了《关于使用部分闲置募集资金 （含超募资金）和自有资金进行现金管理的议案》，同意公司在确保不影响正常 运营和募集资金投资项目建设的情况下，使用不超过人民币 2.5 亿元（含 2.5 亿 元）的闲置募集资金（含超募资金）及不超过人民币 2.5 亿元（含 2.5 亿元）的 自有资金进行现金管理，上述额度自股东大会审议通过之日起 12 个月内有效。 在上述额度和期限范围内，资金可循环滚动使用，并授权公司管理层在额度范 围内行使相关决策权、签署相关合同文件等。具体内容详见公司于 2024 年 12 月 19 日及 ...

7月30日，粤万年青大宗交易成交13万股，成交额204.88万元，占当日总成交额的2.74%，成交价15.76元，较市场收盘价 17.52元折价10.05%。 | 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-07-30 | 301111 | 粤万年青 | 15.76 | 13.00 | | 204.88 万联证券股份有限 | 广发证券股份有限 | | | | | | | | 公司深圳分公司 | 公司汕头迎宾路证 | | | | | | | | | 券营业部 | ...

Market Overview - The Chinese medicine sector rose by 1.0% on July 29, with Foci Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3609.71, up 0.33%, while the Shenzhen Component Index closed at 11289.41, up 0.64% [1] Top Gainers in Chinese Medicine Sector - Foci Pharmaceutical (002644) closed at 10.69, up 9.98% with a trading volume of 841,300 shares and a turnover of 876 million yuan [1] - Zhongsheng Pharmaceutical (002317) also rose by 9.98% to 19.73, with a trading volume of 1,168,400 shares and a turnover of 2.26 billion yuan [1] - Other notable gainers include: - Zhendong Pharmaceutical (300158) up 6.66% to 7.69 [1] - Huasen Pharmaceutical (002907) up 6.50% to 18.51 [1] - Kangjia Pharmaceutical (600557) up 5.61% to 16.58 [1] Top Losers in Chinese Medicine Sector - Qidi Pharmaceutical (000590) fell by 2.65% to 12.13, with a trading volume of 134,500 shares and a turnover of 163 million yuan [2] - Zhenbaodao (603567) decreased by 2.21% to 12.40, with a trading volume of 182,700 shares and a turnover of 227 million yuan [2] - Other notable losers include: - Yunnan Baiyao (000538) down 1.20% to 55.82 [2] - Kangmei Pharmaceutical (600518) down 0.94% to 2.10 [2] Capital Flow Analysis - The Chinese medicine sector saw a net inflow of 798 million yuan from institutional investors, while retail investors experienced a net outflow of 625 million yuan [2][3] - Notable net inflows from institutional investors include: - Zhongsheng Pharmaceutical (002317) with a net inflow of 308 million yuan [3] - Zhendong Pharmaceutical (300158) with a net inflow of 96.32 million yuan [3] - Conversely, significant net outflows from retail investors were observed in: - Zhongsheng Pharmaceutical (002317) with a net outflow of 98.88 million yuan [3] - Zhendong Pharmaceutical (300158) with a net outflow of 65.62 million yuan [3]

Core Viewpoint - The company, Yue Wannianqing, announced a share reduction plan involving its controlling shareholder and significant shareholders, which will not affect the company's control or governance structure [1][2]. Group 1: Share Reduction Plan - The controlling shareholder, Shantou Yinkang Enterprise Management Consulting Partnership, and the shareholder Hehe Investment Holdings plan to reduce their holdings by a total of up to 9,600,000 shares, representing no more than 6.00% of the company's total share capital [1]. - Shantou Yinkang intends to reduce its holdings by up to 4,800,000 shares (3.00% of total share capital), while Hehe Investment also plans to reduce by up to 4,800,000 shares (3.00% of total share capital) [1]. - As of the announcement date, Shantou Yinkang holds 5,861,520 shares (3.66% of total share capital), and Hehe Investment holds 16,000,000 shares (10.00% of total share capital) [1]. Group 2: Company Background - The controlling shareholder of Yue Wannianqing is Guangdong Jino Health Technology Co., Ltd., with actual controllers being Ou Xiantao and Li Yinghua [2]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 7, 2021, with an initial public offering of 40 million shares at a price of 10.48 yuan per share [2]. - The company raised a total of 419 million yuan from its initial public offering, with a net amount of 370 million yuan after deducting issuance costs [3]. Group 3: Financial Performance - The company reported operating revenues from 2019 to 2024 as follows: 317 million yuan, 341 million yuan, 350 million yuan, 283 million yuan, 292 million yuan, and 279 million yuan [4]. - The net profit attributable to shareholders for the same period was 66.63 million yuan, 62.52 million yuan, 57.18 million yuan, 33.42 million yuan, 33.50 million yuan, and 4.16 million yuan [4]. - The net cash flow from operating activities for the years 2019 to 2024 was reported as 48.70 million yuan, 90.90 million yuan, 71.63 million yuan, 69.88 million yuan, -12.80 million yuan, and 3.21 million yuan [4].

Mergers and Acquisitions - Aladdin announced its participation in the auction for 81.96% equity of Kasma Holdings, with a transfer base price of 202 million yuan, aiming to expand sales channels and integrate downstream resources [1] - *ST Baoshi received approval from the Ningxia State-owned Assets Supervision and Administration Commission for the acquisition of 100% equity of Ningxia Electric Power Investment New Energy Co., Ltd. through major asset replacement and cash payment [2] - Guotou Zhonglu disclosed a transaction plan to acquire 100% shares of China Electronic Engineering Design Institute through share issuance, with the specific transaction price yet to be determined [3] Shareholding Changes - MaiPu Medical announced that shareholder Tang Ying plans to reduce holdings by no more than 1% of the company's shares, totaling up to 665,100 shares [4] - Yue Wannianqing disclosed that a 10% shareholder, Hehe Investment, plans to reduce holdings by no more than 6% of the company's shares, totaling up to 4.8 million shares [5] - *ST Huawang announced that shareholder Wu Qun plans to reduce holdings by no more than 1.76% of the company's shares, totaling up to 15,414,300 shares [6] Regulatory Issues - Liuhua Co. received an administrative regulatory decision from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to fulfill obligations regarding the integrity of appointed directors and supervisors [7] - *ST Huike was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8][9] - Tuisijingang announced that two vice presidents were arrested for violating important information disclosure laws, but stated that this would not impact the company's normal operations [10]

Key Points - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets on July 4, providing insights for investors [2] Group 1: Major Corporate Actions - China Shipbuilding Industry Corporation's absorption and merger with China Shipbuilding Industry Group has been approved by the Shanghai Stock Exchange, pending further regulatory approvals [3] - Aerospace Hongtu's controlling shareholder's action party plans to transfer 5.1% of the company's shares to a private equity fund at a price of 19 yuan per share, totaling 253 million yuan [4] - Guotou Zhonglu plans to acquire 100% of China Electronic Engineering Design Institute through a share issuance, with the transaction price yet to be determined [5] - Haitai Development intends to transfer 100% of its subsidiary's equity for 90.6595 million yuan, aiming to optimize its asset structure [6] - Gensun Bio plans to invest approximately 150 million yuan to build an intelligent production and R&D base, expected to be completed by 2028 [7] - Xinhua Insurance intends to invest 11.25 billion yuan to subscribe to a private equity fund, which has a total size of 22.5 billion yuan [8] - Huaming Equipment has raised its share repurchase fund limit from 200 million yuan to 250 million yuan [9] - Aotewei's controlling shareholders plan to transfer 4.99% of the company's shares through a pricing inquiry [10] - Jianke Institute plans to publicly transfer 40% of its stake in Hubei Jiansheng Engineering Technology Consulting Co., Ltd. [11] - Aerospace Electronics plans to increase capital in its subsidiary to enhance its capabilities in unmanned systems [12] Group 2: Financial Performance - Jin Xin Nong reported a 1.23% year-on-year decline in pig sales revenue for the first half of 2025, totaling 763 million yuan [14] - Tianbang Food's June pig sales revenue decreased by 4.01% month-on-month, with a total of 4.143 billion yuan for the first half of 2025 [15] - GAC Group's June automobile sales fell by 8.22% year-on-year, with a total of 755,300 vehicles sold in the first half of 2025, down 12.48% [16] - Pulite expects a net profit increase of 38.88% to 66.65% for the first half of 2025, driven by growth in modified materials and new energy businesses [18] - Zhuye Group anticipates a net profit increase of 50.97% to 75.23% for the first half of 2025, benefiting from rising precious metal prices [19] - Xindong Lian Ke expects a net profit increase of 144.46% to 199.37% for the first half of 2025, supported by sufficient orders and revenue growth [20] - Zhongce Rubber forecasts a net profit decrease of 6.3% to 11.81% for the first half of 2025, due to a one-time gain in the previous year [21] - *ST Sihua expects a net loss of 11 million to 17 million yuan for the first half of 2025, despite significant sales order growth [22] - Sankeshu anticipates a net profit increase of 80.94% to 119.04% for the first half of 2025, driven by growth in retail business and improved gross margins [23] Group 3: Major Contracts and Shareholding Changes - Hongsheng Huayuan's subsidiary is expected to win a bid for a project worth approximately 1.127 billion yuan from the Southern Power Grid [25] - Times New Materials signed contracts worth approximately 2.711 billion yuan for wind turbine blade sales in the second quarter of 2025 [26] - Guojian Group's controlling shareholder reduced its holdings of convertible bonds by 900,000 units, accounting for 11.25% of the total issuance [27] - Yue Wanniang's controlling shareholder plans to reduce its stake by up to 6% through various trading methods [28] - Maipu Medical's shareholder plans to reduce its stake by up to 665,100 shares, representing 0.9999% of the total shares [29] - Jiulian Technology's directors and senior management plan to reduce their holdings by up to 2.61% of the total shares [30] - *ST Huawang's shareholder plans to reduce its stake by up to 1.76% through trading methods [32]

Financial Performance - Whirlpool expects a net profit of approximately 205 million yuan for the first half of 2025, an increase of about 174 million yuan or approximately 559% year-on-year [2] - Chipmotion Technology anticipates a net profit between 138 million to 169 million yuan for the first half of 2025, representing a year-on-year growth of approximately 144.46% to 199.37% [2] Mergers and Acquisitions - China Shipbuilding's absorption merger with China Shipbuilding Industry Corporation has been approved by the Shanghai Stock Exchange, pending further regulatory approvals [3] - Guotou Zhonglu plans to acquire 100% of China Electronic Engineering Design Institute through a share issuance, which constitutes a major asset restructuring [4] Shareholder Actions - Aotewei's actual controllers plan to transfer 4.99% of the company's shares, totaling 15.75 million shares, due to personal funding needs [5] - Yaguang Technology's chairman has been placed under detention, but the company's operations remain normal [5] Industry Developments - Ningbo Port expects a 9.8% year-on-year increase in container throughput for the first half of 2025 [8] - Three Trees anticipates a net profit growth of 80.94% to 119.04% for the first half of 2025 [8] - Zhuhai Group expects a net profit increase of 50.97% to 75.23% for the first half of 2025 [8] Project Wins - Sanxing Medical's subsidiary has pre-qualified for a 306 million yuan project with Southern Power Grid [8] - Hopu Co., Ltd. has jointly won a 449 million yuan shared energy storage demonstration project [8] - Hongsheng Huayuan's subsidiary has pre-qualified for an 1.127 billion yuan project with Southern Power Grid [8]

Core Viewpoint - Hehe Investment, a shareholder holding more than 5% of the shares, plans to reduce its stake in Guangdong Wannianqing (301111) by up to 4.8 million shares, representing 3.00% of the company's total share capital, within three months after the announcement date [1] Summary by Category - **Shareholder Actions** - Hehe Investment intends to reduce its holdings through centralized bidding and block trading methods [1] - The reduction will occur within three months following the announcement, starting 15 trading days after the disclosure [1] - **Company Impact** - The planned reduction of shares may influence market perception and stock performance of Guangdong Wannianqing [1] - The total shares to be reduced account for 3.00% of the company's total share capital, indicating a significant divestment [1]

证券代码：301111 证券简称：粤万年青 公告编号：2025-030 广东万年青制药股份有限公司 关于持股5%以上股东股份减持计划的预披露公告 股东合和投资控股（广州）合伙企业（有限合伙）保证向本公司提供的信 息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 1、股东名称：合和投资控股（广州）合伙企业（有限合伙） 2、股东持股情况：截至本公告披露日，合和投资持有公司股份的总数量为 16,000,000 股，占公司总股本比例 10.00%。 二、本次减持计划的主要内容 1、减持原因：自身资金需求 2、股份来源：公司首次公开发行前已发行股份 3、减持方式：集中竞价交易、大宗交易 4、减持数量及比例：合和投资拟减持股份数量不超过 4,800,000 股，减持比 例不超过公司总股本的 3.00%。减持数量及比例将按照相关法律法规的规定执行： 1 持有广东万年青制药股份有限公司（以下简称"公司"）股份 16,000,000 股 （占公司总股本的 10.00%）的股东合和投资控股（广州）合伙企业（有限合伙） （以下简称"合和投 ...

证券代码：301111 证券简称：粤万年青 公告编号：2025-031 广东万年青制药股份有限公司 关于控股股东、实际控制人之一致行动人股份减持计划的预 披露公告 本公司控股股东、实际控制人之一致行动人汕头市银康企业管理咨询合伙 企业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 1、减持原因：自身资金需求 2、股份来源：公司首次公开发行前已发行股份 3、减持方式：集中竞价交易、大宗交易 1 4、减持数量及比例：银康管理拟减持股份数量不超过 4,800,000 股，减持比 例不超过公司总股本的 3.00%。减持数量及比例将按照相关法律法规的规定执行： 银康管理任意连续 90 个自然日内通过证券交易所集中竞价交易减持股份的总数， 不超过公司股份总数的 1%；任意连续 90 个自然日内通过证券交易所大宗交易减 持股份的总数，不超过公司股份总数的 2%。若在减持计划期间公司有派息、送股、 转增股本、配股等除权除息事项，上述拟减持股份数量将相应进行调整。 广东万年青制药股份有限公司（以下简 ...